Daniel Gereghty
About Daniel Gereghty
Daniel Gereghty is the Manager of Corporate Financial Reporting at Scripps Health in San Diego, California, with extensive experience in financial analysis and reporting.
Manager, Corporate Financial Reporting at Scripps Health
Daniel Gereghty is currently positioned as the Manager of Corporate Financial Reporting at Scripps Health in San Diego, California. In this role, he oversees system administration for multiple financial platforms, including Lawson, Axiom Management Reporting, Essbase, Crystal, and Arcplan. Additionally, he has implemented the standardization of documentation for financial reporting month-end close tasks and scheduled daily automated refreshes for Axiom Management Reporting and SmartView Essbase.
Previous Experience at Life Technologies
In 2011, Daniel Gereghty worked at Life Technologies in Carlsbad, California, as a Senior Financial Analyst within the Financial Planning & Analysis (FP&A) team. His tenure at Life Technologies lasted for five months, during which he took on key financial analysis responsibilities.
Financial Analyst Role at Cymer
Daniel Gereghty also held a contract position at Cymer as a Financial Analyst within the FP&A team in 2011, situated in the Greater San Diego Area. Although his role spanned only two months, it provided him with substantial experience in financial analysis.
Extensive Tenure at Biogen Idec
Daniel Gereghty has an extensive history with Biogen Idec, where he worked from 2002 to 2011. He progressively advanced through roles such as Analyst I, Analyst II, and Analyst III in the Pharmaceutical Operations & Technology and Accounting departments. His last role at Biogen Idec involved a focus on PO&T SBU Control within the Finance Department.
Education at University of Phoenix
Daniel Gereghty attended the University of Phoenix, earning a Bachelor of Science in Business Management & Administration between 2004 and 2007. This educational background provided him with the fundamental knowledge and skills required for his career in financial analysis and corporate financial reporting.